UCLA Health CARE Center

08/16/2025

Tailor fuel to your workout results with the latest nutrition guidance from UCLA Health’s experts.💪 Learn about the best pre-session meals and snacks, whether your focus is strength training or cardio:

08/14/2025

If you are wondering why allergies feel worse this season, the latest data may provide an answer.🤧 Learn how the record-breaking pollen counts this year from UCLA Health’s Dr. Eve Glazier and Dr. Elizabeth Ko as we Ask the Doctors:

08/13/2025

Fatigue is more than just burning the candle at both ends. It might be that your iron levels are quietly dipping. Here’s what UCLA Health experts say to watch for:

08/10/2025

Polycystic o***y syndrome (PCOS) isn’t just about reproductive health — it can also impact your heart ❤️. Discover how this condition may increase your risk for cardiovascular issues and what you can do to protect your health:

08/07/2025

08/06/2025

Diagnosed with metastatic breast cancer at 34, Elissa Kalver found expert care at UCLA and launched WeGotThis.org, the first cancer gift registry, to support others and promote care that values both survival and quality of life.

08/01/2025

The LA wildfires that occurred this year may have long-term health effects that we're just beginning to understand.

Join the UCLA Wildfire Research Registry to be part of new studies tracking those impacts. Your input is valuable:

✅ Sign up once.
🔬 Choose your studies.
🌎 Shape the future of health research.
Join the registry now: ucla.in/wildfire-registry

08/01/2025

Once declared eliminated in the U.S., measles is now making a troubling comeback. An outbreak in West Texas earlier this year helped ignite the increase in measles cases, with more than 1,200 cases reported so far this year. Learn more from UCLA Health experts about the causes and how you can help keep you and your family safe:

07/31/2025

Off the mound, but always on when it comes to heartwarming visits. 💙⚾ When Los Angeles Dodgers pitcher Landon Knack visited our UCLA Santa Monica Medical Center Infusion Center, he made the day a little less ordinary, bringing surprises and smiles.
UCLA Jonsson Comprehensive Cancer Center

07/29/2025

At UCLA Health, innovation drives everything we do. For 36 consecutive years, we’ve earned a place on the U.S. News and World Report Honor Roll, and this year, we’re proud to be ranked #1 in both Los Angeles and California, with national recognition in 10 specialties and high performance across all categories.

But our journey doesn’t end here. We’ll keep on pushing boundaries, keep on raising the bar in health care and keep on rising.

Learn more: https://ucla.in/3S82CwA

07/26/2025

UCLA Health is scaling new heights by using patient-specific 3D‑printed bone models to plan orthopedic surgeries. Orthopedic surgeon and David Geffen School of Medicine at UCLA professor, Dr. Andrew Jensen, is an early adopter of the technology and says it helps improve surgical outcomes. Learn how this innovation is reshaping surgical precision and patient outcomes:

07/26/2025

A gifted aerialist who once dazzled crowds at Disneyland, Rachel is back in full-flight after reconstructive surgery. Her torn biceps tendon from April 2024 threatened her career, but UCLA Health’s surgical team helped her reclaim every twist, turn, and swing. Read about her being honored as a Laker for a Day and her triumphant return to performance: https://ucla.in/4f4djdM

Los Angeles Lakers

06/14/2023

Congratulations, Dr. Landovitz!!!

Cheers to the 2023 ACTG Network Award recipients - Fredrick Sawe, Kimberly Scarsi, Rosie Mngqibisa, and Raphael Landovitz! Your exceptional dedication to and patient care is truly commendable.

04/11/2023

Daily Statin Reduces the Risk of Cardiovascular Disease in People Living with HIV, Large NIH Study Finds

A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this....

12/08/2022

A panel of volunteer expert physician scientists were appointed to update the 2020 IAS-USA recommendations. Advances in treatment and prevention of HIV continue to improve outcomes, but challenges and opportunities remain.
https://jamanetwork.com/journals/jama/fullarticle/2799240

09/30/2022

AIDS Walk Los Angeles returns to West Hollywood on Sunday, October 16 and the UCLA CARE Center is inviting you to come walk with us!

All donations to our team go directly to the UCLA CARE Center.

Support Our Team!We are participating in this event to raise money for the UCLA CARE Center.The Center for Clinical AIDS Research and Education (CARE) provides

09/14/2022

The UCLA CARE Center is participating in STOMP (Study of Tecovirimat for Human Monkeypox Virus).

Follow the link to learn more about this exciting new clinical trial.
https://www.uclahealth.org/news/STOMP2022

07/18/2022

There are online pharmacies that produce low-cost generic versions of high-cost medications. In one such model, drugs are available at wholesale cost plus a 15% mark-up, and a nominal pharmacy and shipping fee. Talk with your provider or share with family and friends if this could help cut down on prescription drug costs.

https://costplusdrugs.com/

07/05/2022

Come to Long Beach Pride and show your support, as we stand in solidarity with the LGBTQ community.

https://longbeachpride.com/

07/04/2022

Happy 246th Birthday America! The CARE Center would like to wish you and your family a safe Holiday!

https://www.discoverlosangeles.com/things-to-do/the-best-fourth-of-july-events-in-los-angeles

06/30/2022

A Community Advisory Board (CAB) is a group of volunteers and representatives that provides advice, insights and opinions to clinical researchers, reflecting diverse perspectives within the community. Learn more about participating in a CAB at the UCLA CARE Center.

06/29/2022

CDC recommends Paxlovid for mild to moderate COVID-19 in patients at high risk for progressing to severe disease. Paxlovid should be initiated within five days of symptom onset and has been shown to be about 88% effective at reducing severe COVID disease. Talk with your health care provider to see if this is indicated for you.

06/28/2022

If you are having trouble paying for your medication, you may qualify for the AIDS Drug Assistance Program (ADAP)! Please email ADAP.CARECenter@mednet.ucla.edu for more details.

*Please note that CARE Center ADAP enrollment services are only available to patients who receive their HIV medical care at UCLA.

06/27/2022

Today is National HIV Testing Day, a day first observed on June 27, 1995 to encourage people to get tested for HIV, know their status, and linkage to care and treatment. Please support The Department of Public Health’s Ending the HIV Epidemic initiative for more resources at https://www.lacounty.hiv

06/24/2022

Check out the CHIRP/LA website for an updated list of food bank locations across Los Angeles and their hours of availability at http://www.chirpla.org/page/food-bank-guide

06/23/2022

Tlando is a new, FDA-approved, oral testosterone replacement for adult men who have low testosterone due to certain medical conditions.

06/22/2022

Common reasons to not take medications regularly include fear, cost, misunderstanding, too many meds, mistrust, and others. Learn about strategies to help overcome these obstacles to take your medications regularly.

06/21/2022

Having trouble remembering to take your HIV medication daily? Consider using a Medication Reminder App to help remind you to take your medication regularly. Check out the list of the Top 10 Apps in 2022.

06/16/2022

Treating pre-cancerous cells (high-grade squamous intraepithelial lesions-HSIL) in the a**s with office-based electrocautery, led to an almost 60% reduction in a**l cancer incidence among people with HIV. The UCLA CARE Center ANCHOR Team continues to follow almost 200 participants on this pivotal study.

**lcancer **lcancerprevention

06/15/2022

Cabenuva was approved in January 2021 by the FDA as an injectable treatment for HIV infection in adults. It replaces the current, daily, oral anti-retroviral medications for those who have an undetectable viral load, are on stable ART, and have no history of resistance or treatment failure to either cabotegravir or rilpivirine. The Cabenuva injections are given every two months or six times per year. Talk with your primary care provider about your options.